Generic Drug Sponsors May Discuss Alternative BE Approaches During Pre-ANDA Meetings

 
• By Kate Rawson
  
alternative approach
Final guidance removes a requirement that a PSG meeting be requested within 60 days of a revised PSG's publication. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics